A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Esophagogastric Cancer; Esophagus Cancer; Esophageal Cancer; Gastric Cancer; Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Gastroesophageal Junction Squamous Cell Carcinoma Interventions: Drug: 18F-BMS-986229 Injection; Drug: IV 18F-BMS-986229; Diagnostic Test: PET/CT Scan Sponsors: Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | PET Scan | Research | Study